Billionaire Profile
T
Global Rank
#489

Image: Little, Archibald John, 1838-1908 | Public domain | via Wikimedia Commons

Tse Ping & family

CEO, Pharmaceuticals
CHINA
Real-Time Net Worth
$7.646B
Estimated based on Pharmaceuticals stock value as of April 20, 2026
-0.71% (24h)
Age
74
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
CHINA

Biography

Tse Ping, the guiding force behind Hong Kong-listed Sino Biopharmaceutical, is a prominent figure in the healthcare industry. Born into the influential Dhanin family, he established himself as a successful entrepreneur despite facing challenges during his youth. His source of wealth stems from pharmaceuticals, with a current net worth of $7.6 billion as of March 2026. Tse Ping has dedicated over two decades to pharmaceutical investment and management, leading Sino Biopharmaceutical to become a major player. His career has been marked by significant achievements, including awards for his leadership and innovation.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/20/2026

Wealth Over Time

In-Depth Profile

Early Life

Tse Ping was born into the Dhanin family, a highly influential family in Asia. However, Tse remained in China during the 1950s when most of his family immigrated to Thailand. During the Cultural Revolution, he was sent to the countryside, which affected his access to formal education.

Rise to Success

Tse Ping's career took off with his involvement in the pharmaceutical industry. He founded Sino Biopharmaceutical in 2000, which has since become one of China's most successful drugmakers. Under his leadership, the company has grown significantly, and he has over 21 years of experience in pharmaceutical investment and management. His company produces versions of modernized Chinese medicine.

Key Business Strategies

Tse Ping has focused on strategic acquisitions and innovation. His company's market capitalization reached $17.2 billion USD as of July 29, 2025. Key inflection events include the company's Hong Kong listing in the early 2000s and the 2019 transfer of shares to his son, Eric Tse.

Philanthropy

Tse Ping's family has been involved in charitable initiatives, including supporting education and cultural projects through the China Summit Foundation. The Tse family's wealth has also enabled them to be involved in various philanthropic endeavors, though specific amounts are not readily available in the search results.

Career Milestones

2000

Founded Sino Biopharmaceutical

Established Sino Biopharmaceutical, which focused on the manufacturing of generic drugs.

2005

Forbes Asia Award

Sino Pharmaceuticals won the Forbes Asia “Best Under $1 billion enterprise within the Asia Pacific Region” award.

2008

World Outstanding Chinese Award

Awarded the “World Outstanding Chinese” in Hong Kong and an honorable Doctorate degree by the University of West Alabama, USA.

2015

Stepped down as Chairman

Stepped down as chairman of Sino Biopharmaceutical and ceded the role to his daughter.

2022

Son Became CEO

Son Eric rose to CEO of Sino Biopharmaceutical.

Philanthropy & Social Impact

Education and Culture

China Summit Foundation

Undisclosed

Supports education and cultural initiatives